BUSINESSTHE GUARDIAN WORLD
Tate & Lyle agrees £2.7bn takeover by US rival in new blow to London market
Tate & Lyle, a UK-based company producing artificial sweeteners like Splenda, has agreed to a £2.7bn takeover by US rival Ingredion. The deal, valued at 615p per share (60% above pre-takeover prices), could jeopardize nearly 500 global jobs and marks another setback for London's struggling stock market.
Mentioned
Related Signal
Adjacent reporting
- Tate & Lyle agrees £2.7bn takeover by US rival in new blow to London market
- Tate & Lyle agrees to £2.7bn takeover from US rival Ingredion
- Britain for sale: Ingredients firm Tate & Lyle is snapped up by US rival in £2.7billion deal
- Ingredion Is in Advanced Talks to Acquire Tate & Lyle for £2.7 billion
- Tate and Lyle shares soar after £2.7bn takeover bid from US firm
- Tate & Lyle Gets Up to £2.7 Billion Offer From Ingredion